Correlation Between Inrom Construction and Biomedix Incubator

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inrom Construction and Biomedix Incubator at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inrom Construction and Biomedix Incubator into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inrom Construction Industries and Biomedix Incubator, you can compare the effects of market volatilities on Inrom Construction and Biomedix Incubator and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inrom Construction with a short position of Biomedix Incubator. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inrom Construction and Biomedix Incubator.

Diversification Opportunities for Inrom Construction and Biomedix Incubator

0.76
  Correlation Coefficient

Poor diversification

The 3 months correlation between Inrom and Biomedix is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Inrom Construction Industries and Biomedix Incubator in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomedix Incubator and Inrom Construction is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inrom Construction Industries are associated (or correlated) with Biomedix Incubator. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomedix Incubator has no effect on the direction of Inrom Construction i.e., Inrom Construction and Biomedix Incubator go up and down completely randomly.

Pair Corralation between Inrom Construction and Biomedix Incubator

Assuming the 90 days trading horizon Inrom Construction Industries is expected to generate 0.44 times more return on investment than Biomedix Incubator. However, Inrom Construction Industries is 2.28 times less risky than Biomedix Incubator. It trades about 0.44 of its potential returns per unit of risk. Biomedix Incubator is currently generating about -0.11 per unit of risk. If you would invest  130,269  in Inrom Construction Industries on August 29, 2024 and sell it today you would earn a total of  27,031  from holding Inrom Construction Industries or generate 20.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Inrom Construction Industries  vs.  Biomedix Incubator

 Performance 
       Timeline  
Inrom Construction 

Risk-Adjusted Performance

27 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Inrom Construction Industries are ranked lower than 27 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Inrom Construction sustained solid returns over the last few months and may actually be approaching a breakup point.
Biomedix Incubator 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Biomedix Incubator are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Biomedix Incubator sustained solid returns over the last few months and may actually be approaching a breakup point.

Inrom Construction and Biomedix Incubator Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inrom Construction and Biomedix Incubator

The main advantage of trading using opposite Inrom Construction and Biomedix Incubator positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inrom Construction position performs unexpectedly, Biomedix Incubator can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomedix Incubator will offset losses from the drop in Biomedix Incubator's long position.
The idea behind Inrom Construction Industries and Biomedix Incubator pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation